Liver Cancer and Immunotherapy.

Описание: Immunotherapy in liver cancer? It’s not for everyone — but for the right patients, it can offer real survival benefits.
Here’s what to know:
🧬 Hepatocellular carcinoma → Atezolizumab + Bevacizumab if liver function is good
🧪 Bile duct cancer → Traditionally used if MSI-high or TMB-high
💡 But now, drugs like Durvalumab are changing the game — even without genetic markers
🔍 Testing matters. So does timing.
🎥 Dr. Sanket Mehta explains the latest updates in immunotherapy for liver and bile duct cancers.
📩 Share this with someone looking for options beyond chemo — it might open doors.

#Immunotherapy #LiverCancer #HepatocellularCarcinoma #BileDuctCancer #Cholangiocarcinoma #Durvalumab #CheckpointInhibitors #PrecisionOncology #DrSanketMehta #CancerAwarenessIndia #MSIHigh #TMBTesting #AdvancedCancerCare

[immunotherapy for liver cancer], [atezolizumab bevacizumab liver cancer], [durvalumab bile duct cancer], [MSI-high cholangiocarcinoma treatment], [Child Pugh A immunotherapy eligibility], [liver cancer advanced treatment], [precision oncology India], [Dr Sanket Mehta liver cancer]